Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1457-1459

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Liu, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Liu, P.

(Circulation. 1998;98:1457-1459.)
© 1998 American Heart Association, Inc.


Images in Cardiovascular Medicine

Restrictive Cardiomyopathy Secondary to Fabry's Disease

Warren J. Cantor, MD; Jagdish Butany, MB, BS; Mark Iwanochko, MD, MSC; ; Peter Liu, MD

From The Toronto Hospital, Toronto, Ontario, Canada.

Correspondence to Mark Iwanochko, MD, EW5–558, The Toronto Hospital, Western Division, 399 Bathhurst St, Toronto, Ontario, Canada M5T 2S8.

A53-year-old woman presented with progressive dyspnea. Family history was positive for Fabry's disease. Cardiac MRI showed marked thickening of the left ventricle (Figure 1Down, arrow). Cardiac catheterization revealed a mean right atrial pressure of 16 mm Hg with large a waves up to 26 mm Hg (Figure 2Down, arrow). A right ventricular endomyocardial biopsy was performed. Light microscopy (Figure 3Down) showed myocardial fiber hypertrophy and PAS-positive vacuoles. Electron microscopy (Figure 4Down) showed complex concentric lamellar bodies (arrows) characteristic of Fabry's disease. Leukocyte {alpha}-galactosidase activity was decreased, confirming the diagnosis. The patient remained severely symptomatic despite medical therapy and was referred for cardiac transplantation. The explanted heart is shown in Figure 5Down.



View larger version (163K):
[in this window]
[in a new window]
 
Figure 1. Cardiac MRI (T1-weighted spin echo). Field of view 24x24 cm. Slice thickness 5 mm. Coronal view (TE=12 ms, TR=869 ms).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Right atrial pressure tracing with simultaneous ECG.



View larger version (119K):
[in this window]
[in a new window]
 
Figure 3. Light microscopy of tissue from cardiac biopsy (Elastic trichrome stain. Original magnification x200).



View larger version (163K):
[in this window]
[in a new window]
 
Figure 4. Electron microscopy of cardiac tissue (original magnification x2000).



View larger version (146K):
[in this window]
[in a new window]
 
Figure 5. Gross specimen of explanted heart.

Footnotes

The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.

Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner Ave, MC1–267, Houston, TX 77030.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. Breunig and C. Wanner
Enzyme replacement therapy for Fabry disease: proving the clinical benefit
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 7 - 9.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Kampmann, F. Baehner, C. Whybra, C. Martin, C. M. Wiethoff, M. Ries, A. Gal, and M. Beck
Cardiac manifestations of Anderson-Fabry disease in heterozygous females
J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1668 - 1674.
[Abstract] [Full Text] [PDF]